Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy.

Sandra AskmanJulia WesterlundÅsa Pettersson Thomas Hellmark Åsa C M Johansson Stina Wichert Markus Hansson

Published in: European journal of haematology (2024)

Our results show that MM patients have neutrophil dysfunction that could contribute to susceptibility for bacterial infections and that lenalidomide therapy was associated with restored PMN function.

Keyphrases

newly diagnosed
multiple myeloma
end stage renal disease
ejection fraction
chronic kidney disease
stem cells
patient reported outcomes
low dose
replacement therapy